Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egon Persson

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanismLongguang Jiang, Xie Xie, Jinyu Li, et al.
Protein Science : a Publication of the Protein Society|March 27, 2007
A combined structural dynamics approach identifies a putative switch in factor VIIa employed by tissue factor to initiate blood coagulationOle H Olsen, Kasper D Rand, Henrik Østergaard, et al.
The Journal of Biological Chemistry|October 26, 2014
Sites involved in intra- and interdomain allostery associated with the activation of factor VIIa pinpointed by hydrogen-deuterium exchange and electron transfer dissociation mass spectrometryHongjian Song, Ole H Olsen, Egon Persson, et al.
Biochemical and Biophysical Research Communications|September 20, 2011
Effects on the conformation of FVIIa by sTF and Ca²⁺ binding: studies of fluorescence resonance energy transfer and quenchingKarin Carlsson, Egon Persson, Mikael Lindgren, et al.
Seminars in Thrombosis and Hemostasis|April 19, 2012
Vatreptacog alfa from conception to clinical proof of conceptEgon Persson, Ole H Olsen, Søren E Bjørn, et al.
Blood|January 22, 2011
Activation peptides prolong the murine plasma half-life of human factor VIILinda Johansson, Ditte M Karpf, Lene Hansen, et al.
European Journal of Biochemistry|June 6, 2003
Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitorKarin Carlsson, Per-Ola Freskgård, Egon Persson, et al.
Biochemical and Biophysical Research Communications|October 21, 2005
Sequential coagulation factor VIIa domain binding to tissue factorMaria Osterlund, Egon Persson, Uno Carlsson, et al.
Biochemical and Biophysical Research Communications|January 15, 2005
Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathwayMaria Osterlund, Egon Persson, Magdalena Svensson, et al.
Thrombosis Research|January 19, 2015
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrateTomas L Lindahl, Maria Wallstedt, Kerstin M Gustafsson, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanismLongguang Jiang, Xie Xie, Jinyu Li, et al.
Protein Science : a Publication of the Protein Society|March 27, 2007
A combined structural dynamics approach identifies a putative switch in factor VIIa employed by tissue factor to initiate blood coagulationOle H Olsen, Kasper D Rand, Henrik Østergaard, et al.
The Journal of Biological Chemistry|October 26, 2014
Sites involved in intra- and interdomain allostery associated with the activation of factor VIIa pinpointed by hydrogen-deuterium exchange and electron transfer dissociation mass spectrometryHongjian Song, Ole H Olsen, Egon Persson, et al.
Biochemical and Biophysical Research Communications|September 20, 2011
Effects on the conformation of FVIIa by sTF and Ca²⁺ binding: studies of fluorescence resonance energy transfer and quenchingKarin Carlsson, Egon Persson, Mikael Lindgren, et al.
Seminars in Thrombosis and Hemostasis|April 19, 2012
Vatreptacog alfa from conception to clinical proof of conceptEgon Persson, Ole H Olsen, Søren E Bjørn, et al.
Blood|January 22, 2011
Activation peptides prolong the murine plasma half-life of human factor VIILinda Johansson, Ditte M Karpf, Lene Hansen, et al.
European Journal of Biochemistry|June 6, 2003
Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitorKarin Carlsson, Per-Ola Freskgård, Egon Persson, et al.
Biochemical and Biophysical Research Communications|October 21, 2005
Sequential coagulation factor VIIa domain binding to tissue factorMaria Osterlund, Egon Persson, Uno Carlsson, et al.
Biochemical and Biophysical Research Communications|January 15, 2005
Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathwayMaria Osterlund, Egon Persson, Magdalena Svensson, et al.
Thrombosis Research|January 19, 2015
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrateTomas L Lindahl, Maria Wallstedt, Kerstin M Gustafsson, et al.
Pageof 5